Biotricity, Inc. (BTCY)
Biotricity has a market cap or net worth of $7.10 million. The enterprise value is $27.57 million.
The last earnings date was Tuesday, November 14, 2023, after market close.
|Earnings Date||Nov 14, 2023|
Biotricity has 8.77 million shares outstanding. The number of shares has increased by 1.77% in one year.
|Shares Change (YoY)||+1.77%|
|Shares Change (QoQ)||+0.49%|
|Owned by Insiders (%)||18.54%|
|Owned by Institutions (%)||5.42%|
|EV / Earnings||n/a|
|EV / Sales||2.48|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 0.29
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-261.60%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||$202,067|
|Profits Per Employee||-$310,687|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -87.32% in the last 52 weeks. The beta is 2.35, so Biotricity's price volatility has been higher than the market average.
|52-Week Price Change||-87.32%|
|50-Day Moving Average||1.63|
|200-Day Moving Average||2.89|
|Relative Strength Index (RSI)||27.75|
|Average Volume (30 Days)||23,804|
Short Selling Information
The latest short interest is 141,139, so 1.61% of the outstanding shares have been sold short.
|Short Previous Month||135,095|
|Short % of Shares Out||1.61%|
|Short % of Float||2.01%|
|Short Ratio (days to cover)||4.30|
In the last 12 months, Biotricity had revenue of $11.11 million and -$17.09 million in losses. Loss per share was -$1.96.
|Loss Per Share||-$1.96|
The company has $1.28 million in cash and $21.40 million in debt, giving a net cash position of -$20.12 million or -$2.29 per share.
|Cash & Cash Equivalents||1.28M|
|Net Cash Per Share||-$2.29|
|Equity / Book Value||-26.73M|
|Book Value Per Share||-3.05|
|Operating Cash Flow||-9.28M|
|Free Cash Flow||-9.28M|
|FCF Per Share||-$1.06|
Gross margin is 61.66%, with operating and profit margins of -99.02% and -153.75%.
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 1:6.
|Last Split Date||Jul 3, 2023|
Biotricity has an Altman Z-Score of -31.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.